bazedoxifene has been researched along with Age-Related Osteoporosis in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (34.78) | 29.6817 |
| 2010's | 15 (65.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anastasilakis, AD; Makras, P; Yavropoulou, MP | 1 |
| Adami, S; Fracassi, E; Gatti, D; Lello, S; Rossini, M; Sblendorio, I; Viapiana, O | 1 |
| Cucalón, JM; Guiu, M | 1 |
| Gallagher, JC; Tella, SH | 1 |
| Goldstein, SR | 1 |
| Pinkerton, JV; Thomas, S | 1 |
| Beaudart, C; Bruyere, O; Dardenne, N; Emonts, P; Neuprez, A; Reginster, JY | 1 |
| Komm, BS; Pickar, JH | 1 |
| Karel, L; Santoro, N; Umland, EM | 1 |
| Kobayashi, T; Matsumoto, M; Miyamoto, K; Miyamoto, T; Morita, M; Nakamura, M; Oike, T; Sato, Y; Tando, T; Watanabe, R | 1 |
| Chines, AA; Christiansen, C; Constantine, GD; de Villiers, TJ; Genant, HK; Silverman, SL; Vukicevic, S; Zanchetta, JR | 1 |
| Bodine, PV; Kharode, Y; Komm, BS; Lyttle, CR; Miller, CP | 1 |
| Fukawa, T; Kamiya, S; Wada, S | 1 |
| Silverman, SL | 2 |
| Iba, K; Takada, J; Yamashita, T | 1 |
| Endo, I; Matsumoto, T | 1 |
| Mirkin, S; Pickar, JH; Pinkerton, JV; Racketa, J | 1 |
| Rizzoli, R; Uelbelhart, B | 1 |
| Archer, DF; Baracat, E; Constantine, G; Northington, R; Nunes, MG; Pickar, JH; Ronkin, S | 1 |
| Chaki, O | 1 |
| Biskobing, DM | 1 |
13 review(s) available for bazedoxifene and Age-Related Osteoporosis
| Article | Year |
|---|---|
Bazedoxifene for the treatment of osteoporosis.
Topics: Bone Density; Bone Density Conservation Agents; Female; Humans; Indoles; Osteoporosis; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Spinal Fractures | 2019 |
Bazedoxifene + conjugated estrogens in HT for the prevention of osteoporosis and treatment of vasomotor symptoms associated with the menopause.
Topics: Animals; Estrogens; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Osteoporosis; Selective Estrogen Receptor Modulators | 2013 |
Use of SERMs for treatment in postmenopausal women.
Topics: Breast Neoplasms; Clinical Trials as Topic; Dyspareunia; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Osteoporosis; Osteoporosis, Postmenopausal; Postmenopause; Pyrrolidines; Raloxifene Hydrochloride; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Tamoxifen; Tetrahydronaphthalenes; Toremifene | 2014 |
Efficacy and safety of currently marketed anti-osteoporosis medications.
Topics: Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Denosumab; Diphosphonates; Humans; Indoles; Osteoporosis; Parathyroid Hormone; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Thiophenes | 2014 |
Selective estrogen receptor modulators and the combination therapy conjugated estrogens/bazedoxifene: A review of effects on the breast.
Topics: Animals; Breast; Breast Neoplasms; Drug Therapy, Combination; Estradiol; Estrogen Antagonists; Estrogens; Estrogens, Conjugated (USP); Female; Fulvestrant; Humans; Indoles; Osteoporosis; Postmenopause; Protective Factors; Raloxifene Hydrochloride; Risk Assessment; Selective Estrogen Receptor Modulators; Tamoxifen; Toremifene | 2015 |
Bazedoxifene and Conjugated Equine Estrogen: A Combination Product for the Management of Vasomotor Symptoms and Osteoporosis Prevention Associated with Menopause.
Topics: Drug Combinations; Estrogens, Conjugated (USP); Hot Flashes; Humans; Indoles; Menopause; Osteoporosis | 2016 |
[Newly developed drugs for osteoporosis in overseas and their future roles for the therapy].
Topics: Anabolic Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Bone Resorption; Denosumab; Diphosphonates; Drug Design; Evidence-Based Medicine; Fractures, Bone; Humans; Imidazoles; Indoles; Organometallic Compounds; Osteoporosis; RANK Ligand; Selective Estrogen Receptor Modulators; Teriparatide; Thiophenes; Zoledronic Acid | 2008 |
New therapies for osteoporosis: zoledronic acid, bazedoxifene, and denosumab.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Denosumab; Diphosphonates; Female; Humans; Imidazoles; Indoles; Male; Osteoporosis; RANK Ligand; Risk Factors; Treatment Outcome; Zoledronic Acid | 2009 |
New selective estrogen receptor modulators (SERMs) in development.
Topics: Bone Density Conservation Agents; Breast Neoplasms; Female; Humans; Indoles; Osteoporosis; Piperidines; Pyrrolidines; Risk Factors; Selective Estrogen Receptor Modulators; Tetrahydronaphthalenes; Thiophenes | 2010 |
[Diagnostic imaging of treatment in osteoporosis: SERM].
Topics: Absorptiometry, Photon; Bone and Bones; Bone Density; Female; Hip Fractures; Humans; Indoles; Osteoporosis; Raloxifene Hydrochloride; Risk; Selective Estrogen Receptor Modulators; Spinal Fractures; Tomography, X-Ray Computed | 2011 |
Bazedoxifene/conjugated estrogens for menopausal symptom treatment and osteoporosis prevention.
Topics: Adult; Aged; Atrophy; Clinical Trials, Phase III as Topic; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Middle Aged; Osteoporosis; Quality of Life; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Treatment Outcome; Vagina; Vaginal Diseases; Vulva | 2012 |
[Next generation selective estrogen receptor modulators].
Topics: Animals; Bone Density; Bone Density Conservation Agents; Cholesterol; Female; Humans; Indoles; Osteoporosis; Pyrrolidines; Selective Estrogen Receptor Modulators; Tetrahydronaphthalenes; Uterus | 2006 |
Update on bazedoxifene: a novel selective estrogen receptor modulator.
Topics: Animals; Bone Density Conservation Agents; Estrogens; Female; Humans; Indoles; Osteoporosis; Osteoporosis, Postmenopausal; Selective Estrogen Receptor Modulators; Treatment Outcome; Uterus | 2007 |
2 trial(s) available for bazedoxifene and Age-Related Osteoporosis
| Article | Year |
|---|---|
Efficacy of bazedoxifene in reducing new vertebral fracture risk in postmenopausal women with osteoporosis: results from a 3-year, randomized, placebo-, and active-controlled clinical trial.
Topics: Aged; Aged, 80 and over; Bone and Bones; Bone Density; Female; Fractures, Bone; Humans; Indoles; Lumbar Vertebrae; Middle Aged; Osteoporosis; Placebos; Postmenopause; Selective Estrogen Receptor Modulators; Time Factors; Treatment Outcome | 2008 |
Endometrial effects of bazedoxifene acetate, a novel selective estrogen receptor modulator, in postmenopausal women.
Topics: Adult; Aged; Double-Blind Method; Endometrium; Female; Humans; Indoles; Menopause; Middle Aged; Osteoporosis; Postmenopause; Selective Estrogen Receptor Modulators; Ultrasonography | 2005 |
8 other study(ies) available for bazedoxifene and Age-Related Osteoporosis
| Article | Year |
|---|---|
Profile of bazedoxifene/conjugated estrogens for the treatment of estrogen deficiency symptoms and osteoporosis in women at risk of fracture.
Topics: Aged, 80 and over; Bone Density; Bone Remodeling; Clinical Trials as Topic; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Indoles; Middle Aged; Osteoporosis; Osteoporotic Fractures; Quality of Life; Selective Estrogen Receptor Modulators | 2013 |
[The enigma of quaternary prevention in Primary Care. When and when not to do it (presentation of two cases)].
Topics: Aged, 80 and over; Androgen Antagonists; Anilides; Bone Density Conservation Agents; Cyproterone; Female; Humans; Inappropriate Prescribing; Indoles; Male; Nitriles; Osteoporosis; Primary Health Care; Prostatic Neoplasms; Tosyl Compounds | 2013 |
Still another selective estrogen receptor modulator to enhance women's health: this time in combination with conjugated equine estrogens.
Topics: Animals; Drug Combinations; Drug Labeling; Dyspareunia; Estrogens; Estrogens, Conjugated (USP); Female; Haplorhini; Humans; Indoles; Osteoporosis; Postmenopause; Selective Estrogen Receptor Modulators | 2014 |
Selective estrogen receptor modulators and the vitamin D analogue eldecalcitol block bone loss in male osteoporosis.
Topics: Animals; Bone and Bones; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Bone Resorption; Indoles; Male; Mice; Mice, Inbred C57BL; Orchiectomy; Osteoporosis; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen; Testosterone; Vitamin D | 2017 |
The pairing of a selective estrogen receptor modulator, bazedoxifene, with conjugated estrogens as a new paradigm for the treatment of menopausal symptoms and osteoporosis prevention.
Topics: Animals; Bone Density; Cholesterol; Estrogens, Conjugated (USP); Female; Indoles; Lipid Metabolism; Osteoporosis; Rats; Rats, Sprague-Dawley; Selective Estrogen Receptor Modulators; Uterus; Vasomotor System | 2008 |
[New approved drugs for osteoporosis in Japan].
Topics: Bone Density Conservation Agents; Diphosphonates; Humans; Imidazoles; Indoles; Japan; Osteoporosis; Parathyroid Hormone; Teriparatide; Vitamin D | 2012 |
[Osteoporosis].
Topics: Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Calcium; Denosumab; Diphosphonates; Female; Humans; Indoles; Osteoporosis; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Risk Assessment; Teriparatide; Treatment Outcome; Vitamin D | 2012 |
Bazedoxifene: bazedoxifene acetate, TSE 424, TSE-424, WAY 140424.
Topics: Animals; Bone Density Conservation Agents; Clinical Trials as Topic; Drug Evaluation, Preclinical; Female; Humans; Indoles; Osteoporosis; Postmenopause; Selective Estrogen Receptor Modulators | 2008 |